Kathleen McElwaney
Obstetrics & Gynecology · Tampa, FLNPI 1891846630
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.0% of the total across 170 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations.
Across 170 payments — averaging $18.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$513
- AbbVie$295
- Myovant Sciences Inc.$247
- Sage Therapeutics, LLC$234
- Sumitomo Pharma America, Inc.$157
- Hologic Sales And Service, LLC$157
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,06296%
- Education$1264%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 16 | $513 |
| AbbVie | 15 | $295 |
| Myovant Sciences Inc. | 15 | $247 |
| Sage Therapeutics, LLC | 12 | $234 |
| Sumitomo Pharma America, Inc. | 13 | $157 |
| Hologic Sales And Service, LLC | 7 | $157 |
| Mayne Pharma Commercial LLC | 6 | $136 |
| Amgen | 9 | $134 |
| Daiichi Sankyo Inc. | 6 | $116 |
| Pfizer | 8 | $114 |
| Organon | 5 | $113 |
| Evofem Biosciences, Inc. | 6 | $111 |
| Agile Therapeutics, Inc. | 7 | $99 |
| Therapeuticsmd, Inc. | 7 | $99 |
| Bayer | 5 | $92 |
| Millicent US Inc | 4 | $81 |
| Radius Health, Inc. | 3 | $67 |
| Mylan Pharmaceuticals Inc. | 4 | $55 |
| Exeltis, USA Inc. | 3 | $51 |
| Lupin Inc. | 2 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| Supernus Pharmaceuticals, Inc. | 1 | $28 |
| Coopersurgical, Inc. | 2 | $24 |
| Coloplast | 1 | $22 |
| Abbott | 1 | $22 |
| Northgate Technologies, Inc. | 1 | $18 |
| Aspira Women's Health Inc | 1 | $18 |
| Roche Diagnostics Corporation | 1 | $17 |
| Exact Sciences | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Shield Therapeutics Inc | 1 | $14 |
| Boston Scientific | 1 | $14 |
| Radiometer America, Inc | 1 | $13 |
| Medicem Inc. | 1 | $13 |
| Avion Pharmaceuticals | 1 | $12 |
How this compares
$3,188 in reported general payments places this provider in the 80th percentile of 2,438 obstetrics & gynecology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 12 | $594 |
| Oxybutynin Chloride ErOxybutynin Chloride | 11 | $489 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Tampa
- Elliot CazesTampa$725K
- Daniel GomezTampa$311K
- Michael StineTampa$220K
- Matthew AndersonTampa$136K
- Erin GeorgeTampa$54K
- Emad MikhailTampa$26K
- Rachel RapkinTampa$25K
- Diana EnglishTampa$23K
- Steven McCarusCelebration$2.3M
- Charles BloomWinter Park$652K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.